This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Dart Therapeutics LLC, Galapagos Nv. Active years: 2011-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2013
Title: Pierre Deprez: Innovator in Pharmaceutical Compounds
Introduction
Pierre Deprez is a notable inventor based in Romainville, France. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel compounds. With a total of 2 patents, his work focuses on improving health outcomes for various conditions affecting mammals, including humans.
Latest Patents
Among his latest patents, Pierre Deprez has developed imidazolidine compounds that serve as androgen receptor modulators. These novel compounds are represented by a specific formula, which includes various components as described in his patent documentation. The compounds can be formulated into pharmaceutical compositions and are intended for the prevention and treatment of a range of conditions, such as cachexia, osteoporosis, sarcopenia, and sexual dysfunction.
Career Highlights
Throughout his career, Pierre has worked with several prominent companies in the pharmaceutical industry. Notably, he has been associated with Dart Therapeutics LLC and Galapagos NV. His expertise in the field has allowed him to contribute to innovative solutions that address critical health issues.
Collaborations
Pierre has collaborated with several professionals in his field, including Roland Blanqué and Catherine Jagerschmidt. These partnerships have further enhanced his research and development efforts.
Conclusion
In summary, Pierre Deprez is a distinguished inventor whose work in pharmaceutical compounds has the potential to significantly impact health care. His innovative approaches to treating various conditions highlight the importance of research and development in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
